Related Experiment Videos
Kinetic study of rheumatoid factor influence on complement-mediated modulation of immune precipitation
Abstract:
Human monoclonal IgM kappa rheumatoid factor PA (mRF) expressed various effects on complement-dependent modulation of ovalbumin/antiovalbumin lattice formation measured kinetically by laser light scattering (LLS): (1) in the absence of complement, mRF (44.2-177 U/ml) caused enhancement of LLS in a dose-dependent manner; (2) mRF partially prevented expression of complement-mediated inhibition of lattice formation and, at the same time, complement inhibits mRF-dependent LLS enhancement; (3) complement caused disruption of lattice-mRF bonds during solubilization of preformed lattice-mRF complex as demonstrated by specific mRF activity in supernatants. This effect is dependent on complement activity and on both complement and mRF concentrations; (4) ovalbumin/antiovalbumin complexes gradually lost the ability to react with mRF during the first 2 min of complement-mediated inhibition of lattice formation.
Insights
Human monoclonal IgM rheumatoid factor (mRF) influences complement-mediated lattice formation. Complement can inhibit mRF
Area of Science:
- Immunology
- Rheumatology
- Biochemistry
Background:
- Rheumatoid factors (RFs) are autoantibodies involved in autoimmune diseases like rheumatoid arthritis.
- The interaction between RFs, immune complexes, and the complement system is complex and not fully understood.
- Understanding these interactions is crucial for elucidating disease pathogenesis and developing targeted therapies.
Purpose of the Study:
- To investigate the effects of human monoclonal IgM rheumatoid factor (mRF) on complement-dependent immune complex lattice formation.
- To characterize the modulatory roles of mRF and complement in the kinetics of lattice formation and dissolution.
- To explore how complement influences the binding of mRF to immune complexes.
Main Methods:
- Laser light scattering (LLS) was used to kinetically measure ovalbumin/antiovalbumin lattice formation.
- Human monoclonal IgM kappa rheumatoid factor (mRF) was added at varying concentrations (44.2-177 U/ml).
- Complement activity was introduced to assess its impact on mRF-mediated lattice formation and complex stability.
Main Results:
- In the absence of complement, mRF enhanced lattice formation in a dose-dependent manner.
- Complement partially inhibited mRF-mediated lattice enhancement and, conversely, mRF partially prevented complement-mediated inhibition.
- Complement induced the disruption of preformed lattice-mRF complexes, releasing active mRF, dependent on complement and mRF concentrations.
- Immune complexes lost reactivity with mRF within 2 minutes of complement-mediated inhibition.
Conclusions:
- Human monoclonal IgM rheumatoid factor (mRF) exhibits complex, dose-dependent interactions with complement during immune complex lattice formation.
- Complement plays a dual role, inhibiting mRF-enhanced lattice formation while also being capable of disrupting existing mRF-containing immune complexes.
- These findings highlight the dynamic interplay between mRF, immune complexes, and complement, offering insights into the immunopathology of RF-associated conditions.